BMY
Bristol-Myers Squibb Company
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Bristol-Myers Squibb Company (BMY) is a leading biopharmaceutical firm based in New York City, recognized for its pioneering advancements in oncology, immunology, cardiovascular diseases, and hematology. With a robust portfolio of established therapies and a strong pipeline focused on addressing sig...
$62.34
-0.05% ($0.03)
Volume
17.63M
52W High
$63.33
52W Low
$42.52
Market Cap
$100.17B
What to Watch This Quarter
Based on historical dataConsensus EPS
$1.46
Whisper EPS
$1.50
2.6% above consensus
Last Quarter
$1.26
Current Streak
2 Misss
Avg Surprise (4Q)
+2.16%
Next Earnings Report
Reports in 49 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q4 2025
Feb 5, 2026
1-Day:
+4.15%
5-Day:
+2.25%
Q3 2025
Oct 30, 2025
1-Day:
+0.99%
5-Day:
-0.07%
Q2 2025
Jul 31, 2025
1-Day:
+2.12%
5-Day:
+5.86%
Q1 2025
Apr 24, 2025
1-Day:
-1.62%
5-Day:
+1.09%
Revenue & Financial Performance
Revenue Whisper
$12.17B
TWN Proprietary Estimate
Last Quarter Revenue
$12.50B
+1.3% YoY
Gross Margin
67.2%
Net Margin: 8.7%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $12.50B | +1.3% | 67.2% | 11.4% | $1.09B |
| Q3'25 | $12.22B | +2.8% | 71.9% | 29.8% | $2.20B |
| Q2'25 | $12.27B | +0.6% | 65.8% | 33.6% | $1.31B |
| Q1'25 | $11.20B | -5.6% | 65.5% | 31.4% | $2.46B |
| Q4'24 | $12.34B | +7.5% | 60.2% | 20.5% | $72.0M |
| Q3'24 | $11.89B | +8.4% | 55.6% | 19.2% | $1.21B |
| Q2'24 | $12.20B | +8.7% | 55.7% | 21.2% | $1.68B |
| Q1'24 | $11.87B | +4.7% | 55.5% | 12.9% | -$11.91B |
Company Information
Symbol
BMY
Company
Bristol-Myers Squibb Company
Market Cap
$100.17B
Sector
HEALTHCARE
Next Earnings
Apr 23, 2026
Also Reporting Soon
Companies reporting earnings around the same time as BMY
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare BMY with competitors
Side-by-side earnings comparison